20 March, 2017 by The TZ Newswire Staff Comments Off on Why Aevi Genomic Medicine Got Crushed Today
Why Aevi Genomic Medicine Got Crushed Today
Aevi Genomic Medicine (NASDAQ: GNMX), which used to go by Medgenics, is down 57% at 12:36 p.m. EDT after the company announced that its ADHD medication, AEVI-001, failed a phase 2/3 clinical trial called SAGA.
SAGA tested AEVI-001 in adolescents 12 to 17 years old with ADHD who have a mutation in mGluR. The mGluR mutation causes a glutamate imbalance in patients, which Aevi Genomic Medicine hopes can be treated with AEVI-001, an oral selective activator/modulator of mGluRs.
Image source: Getty Images.
20 March, 2017 by The TZ Newswire Staff Comments Off on Dijsselbloem: "Let’s be realistic, my turn as fin min will certainly come to an end"
Dijsselbloem: "Let’s be realistic, my turn as fin min will certainly come to an end"
Dijsselbloem will be shuffled out with new government
Dijsselbloem’s party won the most seats in the Dutch election but he has indicated that in all the horse-trading of a new coalition, he will be left out.
20 March, 2017 by The TZ Newswire Staff Comments Off on What to Watch When GameStop Corp. Posts Fiscal Q4 Earnings
What to Watch When GameStop Corp. Posts Fiscal Q4 Earnings
These are not happy times for the disc-based video game retailing industry. Market leader GameStop (NYSE: GME) is enduring a brutal customer traffic slump that’s being amplified by the growth of digital downloads.
That trend has been great for publishers like Activision Blizzard, whose profit margin just set a new record. But GameStop loses out on the initial sale and also any possibility of profiting from a trade-in.
20 March, 2017 by The TZ Newswire Staff Comments Off on Why Amgen’s Success Was a Big Disappointment
Why Amgen’s Success Was a Big Disappointment
Amgen, Inc. (NASDAQ: AMGN) recently released conclusive proof that its pricey new cholesterol-lowering drug saves lives. As hoped, results of a long-awaited outcome study showed that people taking Repatha were far less likely to suffer heart attacks and strokes.
Instead of lifting the stock as you might expect, the market shaved about $8.5 billion from the biotech’s market cap on the day it released the news. If the negative reaction to the great news has you scratching your head, you’re not alone.
20 March, 2017 by The TZ Newswire Staff Comments Off on Understanding the Low Volatility Advantage
Understanding the Low Volatility Advantage
Low volatility ETFs are not intended to outperform during bull markets. Instead, look at how they do when stocks tumble.
20 March, 2017 by The TZ Newswire Staff Comments Off on The World’s Wealthiest People Under Age 35
The World’s Wealthiest People Under Age 35
The fortunes of the wealthiest individuals under age 35 were, in large proportion, amassed by founding technology-related firms. Here is the list.
20 March, 2017 by The TZ Newswire Staff Comments Off on Fed’s Evans: Supports two or three hikes in 2017
Fed’s Evans: Supports two or three hikes in 2017
Fed’s Evans in New York
– Supports two or three hikes in 2017
– Expects Fed rate hike path to unfold along median path
– Business investment is somewhat disappointing
Evans is important this year because he’s a voter. If he shifts towards Kashkari’s thinking, that would be two dissents on the dovish side. But for now, he’s not in that mindset.